Cell-specific mechanism-based gene therapy approach to treat retinitis pigmentosa
Friday, September 30, 2011 - 15:00
in Biology & Nature
In a paper published in the October 2011 issue of Experimental Biology and Medicine, a team of researchers at Columbia University Medical Center led by Stephen Tsang, MD, Ph.D have achieved temporary functional preservation of photoreceptors in a mouse model for retinitis pigmentosa (RP) using novel bipartite gene therapy.